Epidemiological study of Infection by resistant organisms & their Gene expression in Post Covid Era- An Observational Study in a tertiary center ICU
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- To record the organisms identified in samples of ICU patients using multiplex PCR along with the resistance genes expressed by them
研究概览
简要总结
The Multiplex PCR results of all the patients included in the study will be noted. The resistant genes expressed by them will also be documented. The proportion of patient samples showing carbapenem resistance will be calculated. The proportion of patients with infection by multiple organisms will also be calculated. The antibiotics used in the treatment of these patients will be documented. The antibiotic usage and mortality among those infected with organisms expressing genes for carbapenem resistance will also be noted. The proportion of patients with organisms showing Carbapenem resistance (using multiplex PCR in post COVID era patients and the available culture sensitivity reports of patients admitted in pre COVID era) will be compared.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 15.00 Year(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients whose samples were sent for multiplex PCR for Syndromic testing during study period.
排除标准
- •Patients < 15 years of age and >90 years of age.
结局指标
主要结局
To record the organisms identified in samples of ICU patients using multiplex PCR along with the resistance genes expressed by them
时间窗: At Baseline (On admission)
次要结局
- Prevalence of carbapenem resistance genes(At Baseline (On admission))
- Antibiotics used in those infected with carbapenem resistant organisms(At Baseline (On admission))
- 30 days Mortality among those with carbapenem resistance(At Baseline (On admission))
- Prevalence of multi colonization(At Baseline (On admission))
- Comparison with ICU infections by carbapenem resistant organisms in pre COVID era(At Baseline (On admission))
研究者
Bhawesh Upreti
Indira Gandhi Institute of Medical Sciences Patna